NCT02100007 2017-10-02ME-344 Given in Combination With Hycamtin® in Patients With Solid TumorsMEI Pharma, Inc.Phase 1/2 Terminated46 enrolled 17 charts
NCT00276276 2013-04-15Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung CancerGlaxoSmithKlinePhase 3 Completed141 enrolled